Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2005
05/25/2005CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use
05/25/2005CN1203070C Thrombin receptor antagonists
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203060C Pyridine derivatives, its composition and use
05/24/2005US6897319 Therapeutic drugs for treating central nervous system disorders
05/24/2005US6897240 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use
05/24/2005US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability
05/24/2005US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole
05/24/2005US6897227 Prodrugs of proton pump inhibitors
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents
05/24/2005US6897214 Quinazoline derivatives
05/24/2005US6897208 Protein kinase inhibitors
05/24/2005CA2169194C Substituted azadioxacycloalkenes and their use as fungicides
05/19/2005WO2005044817A1 Modulators of cellular adhesion
05/19/2005WO2005044801A1 Pyridine carboxylic acid derivatives as glucokinase modulators
05/19/2005WO2005044308A1 Phosphonate analogs of antimetabolites
05/19/2005WO2005044268A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine
05/19/2005WO2005044256A1 2-azetidinones as anti-hypercholesterolemic agents
05/19/2005WO2005044192A2 Triazole compounds and uses related thereto
05/19/2005WO2004041780A3 N-(indole-2-carbonyl) amides as anti-diabetic agents
05/19/2005US20050107696 Polarizing agents for dynamic nuclear polarization
05/19/2005US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors
05/19/2005US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
05/19/2005US20050107431 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
05/19/2005US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders
05/19/2005US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
05/19/2005US20050107409 drugs such as 3-{[7-(2,5-dihydropyrrol-1-yl-carbonyl)-quinazolin-4-yl]aminomethyl}-4-hydroxy-benzamidine, used as anticoagulants
05/19/2005US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions
05/19/2005US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/19/2005US20050107367 2-(morpholin-4-yl)-6-phenyl-thiopyran-4-one; treating diseases which are retroviral mediated or ameliorated by the inhibition of DNA-PK
05/19/2005US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
05/19/2005US20050107357 2,4-dioxo-3-quinazolinylaryl sulfonylureas
05/19/2005US20050106502 Information recording medium and oxonol compound
05/19/2005CA2544845A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine
05/19/2005CA2544678A1 Modulators of cellular adhesion
05/19/2005CA2543943A1 2-azetidinones as anti-hypercholesterolemic agents
05/19/2005CA2543643A1 Pyridine carboxylic acid derivatives as glucokinase modulators
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/18/2005EP1531155A1 Asymmetrical linear organic oligomers
05/18/2005EP1531154A2 Process for the preparation of linear organic thiophene/phenylene oligomers
05/18/2005EP1530574A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments
05/18/2005EP1250047B9 Herbicidal composition
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament
05/18/2005CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1)
05/18/2005CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617726A N4-acylcytosine nucleosides for treatment of viral infections
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1202203C Dye adulterated organic-inorganic hybridized material
05/18/2005CN1202104C 2-phenylpyran-4-one derivatives
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
05/18/2005CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases
05/17/2005US6894063 Drugs for treating metabolic and eating disorders, diabetes
05/17/2005US6894061 Substituted dihydrophenanthridinesulfonamides
05/17/2005US6894054 Central nervous system disorders; muscular disorders
05/17/2005US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives
05/17/2005US6894042 Azabicyclic compounds for the treatment of disease
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005CA2306782C Isoquinolines as urokinase inhibitors
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/12/2005WO2005043962A1 Charge-transporting organic material containing compound having 1,4-dithiin ring
05/12/2005WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
05/12/2005WO2005042524A1 Pyridine carboxamide and methods for inhibiting hiv integrase
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2005042520A1 Benzimidazolyl derivatives
05/12/2005WO2005042500A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005042488A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005WO2005042487A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005WO2005042486A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005WO2005042444A2 Platinum complex and luminescent element
05/12/2005WO2005032488A3 2,4-dioxo-3-quinazolinylaryl sulfonylureas
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005007635A8 Combretastatin derivatives with cytotoxic action
05/12/2005WO2005003099A3 Pyrimidines useful as modulators of voltage-gated ion channels
05/12/2005US20050101785 Reaction of cyano compound with silylalkylisocyanide for active imidazoles
05/12/2005US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101634 Bis(5-aeyl-2-pyridyl) derivatives
05/12/2005US20050101630 4-Anilino-, phenoxy-, or phenylthio-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101586 Novel 5-HT2A receptor ligands
05/12/2005US20050101584 Selective estrogen receptor-beta ligands
05/12/2005US20050101569 Methods and compositions for selectin inhibition
05/12/2005US20050101568 Methods and compositions for selectin inhibition
05/12/2005US20050101567 Using a sulfonamide containing compound
05/12/2005US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors
05/12/2005US20050098777 Process for the production of linear organic thiophene-phenylene oligomers
05/12/2005CA2544772A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005CA2544763A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 523